🇺🇸 FDA
Patent

US 6046175

Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis

expired A61KA61K31/17A61K31/19

Quick answer

US patent 6046175 (Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/17, A61K31/19, A61K31/70, A61K31/7072